Cargando…
Phase I trial of nedaplatin and S-1 in patients with advanced squamous cell lung cancer
The platinum doublet is considered to be the standard cytotoxic chemotherapy for advanced lung cancer. It has been previously reported that nedaplatin and S-1 have clinical efficacy against squamous cell lung cancer. As the combination of nedaplatin and S-1 has never been studied for advanced squamo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657081/ https://www.ncbi.nlm.nih.gov/pubmed/33194196 http://dx.doi.org/10.3892/mco.2020.2159 |